{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:37:16Z","timestamp":1761536236534,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.jtha.2022.11.003","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T19:22:05Z","timestamp":1673292125000},"page":"18-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thrombosis in hereditary hemorrhagic telangiectasia"],"prefix":"10.1016","volume":"21","author":[{"given":"Caleb J.","family":"Kroll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Kroll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2022.11.003_bib1","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1182\/asheducation-2016.1.620","article-title":"What to do after the bleed: resuming anticoagulation after major bleeding","volume":"2016","author":"Witt","year":"2016","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jtha.2022.11.003_bib2","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1111\/jth.15476","article-title":"Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: communication from the ISTH SSC Subcommittee on Control of Anticoagulation","volume":"19","author":"Candeloro","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.003_bib4","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/j.1538-7836.2010.03860.x","article-title":"Hereditary hemorrhagic telangiectasia: from molecular biology to patient care","volume":"8","author":"Dupuis-Girod","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.003_bib5","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3324\/haematol.2018.193003","article-title":"Hereditary hemorrhagic telangiectasia: diagnosis and management from the hematologist\u2019s perspective","volume":"103","author":"Kritharis","year":"2018","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2022.11.003_bib6","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1038\/s41436-020-0775-8","article-title":"Cura\u00e7ao diagnostic criteria for hereditary hemorrhagic telangiectasia is highly predictive of a pathogenic variant in ENG or ACVRL1 (HHT1 and HHT2)","volume":"22","author":"McDonald","year":"2020","journal-title":"Genet Med"},{"key":"10.1016\/j.jtha.2022.11.003_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgene.2015.00001","article-title":"Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era","volume":"6","author":"McDonald","year":"2015","journal-title":"Front Genet"},{"key":"10.1016\/j.jtha.2022.11.003_bib8","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ajmg.a.62522","article-title":"Clinical manifestations of patients with GDF2 mutations associated with hereditary hemorrhagic telangiectasia type 5","volume":"188","author":"Farhan","year":"2022","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.jtha.2022.11.003_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fgene.2015.00025","article-title":"Mouse models of hereditary hemorrhagic telangiectasia: recent advances and future challenges","volume":"6","author":"Tual-Chalot","year":"2015","journal-title":"Front Genet"},{"key":"10.1016\/j.jtha.2022.11.003_bib10","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.0000000000001538","article-title":"Complications and mortality in hereditary hemorrhagic telangiectasia: a population-based study","volume":"84","author":"Donaldson","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.jtha.2022.11.003_bib11","first-page":"3581","article-title":"Hereditary hemorrhagic telangiectasia (HHT) and survival: the importance of systematic screening and treatment in HHT centers of excellence","volume":"9","author":"de Gussem","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.jtha.2022.11.003_bib12","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.3324\/haematol.2020.261859","article-title":"An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study","volume":"106","author":"Al-Samkari","year":"2021","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2022.11.003_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088812","article-title":"Ischaemic strokes in patients with pulmonary arteriovenous malformations and hereditary hemorrhagic telangiectasia: associations with iron deficiency and platelets","volume":"9","author":"Shovlin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jtha.2022.11.003_bib14","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/jth.15715","article-title":"A\u00a0precision medicine approach to hereditary hemorrhagic telangiectasia and complex vascular anomalies","volume":"20","author":"Al-Samkari","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.003_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12546","article-title":"Tranexamic acid evidence and controversies: an illustrated review","volume":"5","author":"Relke","year":"2021","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.003_bib16","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMc1213554","article-title":"Antiplatelet and anticoagulant agents in hereditary hemorrhagic telangiectasia","author":"Devlin","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2022.11.003_bib17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13023-019-1179-1","article-title":"Safety of direct oral anticoagulants in patients with hereditary hemorrhagic telangiectasia","volume":"14","author":"Shovlin","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtha.2022.11.003_bib18","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1160\/TH07-01-0064","article-title":"Elevated factor VIII in hereditary haemorrhagic telangiectasia (HHT): association with venous thromboembolism","volume":"98","author":"Shovlin","year":"2007","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jtha.2022.11.003_bib19","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/thoraxjnl-2011-201076","article-title":"Low serum iron levels are associated with elevated plasma levels of coagulation factor VIII and pulmonary emboli\/deep venous thromboses in replicate cohorts of patients with hereditary haemorrhagic telangiectasia","volume":"67","author":"Livesey","year":"2012","journal-title":"Thorax"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622071938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622071938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:32:52Z","timestamp":1761535972000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622071938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1538783622071938"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2022.11.003","relation":{},"ISSN":["1538-7836"],"issn-type":[{"type":"print","value":"1538-7836"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thrombosis in hereditary hemorrhagic telangiectasia","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2022.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}